Analysis of Notch2 signaling suggests that reduced levels of Mcl-1, induced by Notch2 silencing, may influence the sensibility of CLL cells to venetoclax treatment (Figures 5B, C; *p < 0.05, **p < 0.01). The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.